Drugs / MMC
last change Nov 2020 re-read 2 minutes ago

MMC

Developed for
hepatocellular carcinoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02973685 Comparator Oct 2016 → Nov 2020 hepatocellular carcinoma Sun Yat-sen University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MMC “lipiodol mixed with chemotherapy drugs(EADM , lobaplatin, with or without MMC)” NCT02973685
Route Other “Hepatic intra-arterial infusion with lipiodol mixed with chemotherapy drugs (EADM , lobaplatin, with or without MMC)” NCT02973685